Pontine reticular formation (PnO) administration of hypocretin-1 increases PnO GABA levels and wakefulness

Christopher J. Watson, Haideliza Soto-Calderon, Ralph Lydic, Helen Baghdoyan

Research output: Contribution to journalArticle

48 Citations (Scopus)

Abstract

Study Objectives: GABAergic transmission in the oral part of the pontine reticular formation (PnO) increases wakefulness. The hypothalamic peptide hypocretin-1 (orexin A) promotes wakefulness, and the PnO receives hypocretinergic input. The present study tested the hypothesis that PnO administration of hypocretin-1 increases PnO GABA levels and increases wakefulness. This study also tested the hypothesis that wakefulness is either increased or decreased, respectively, by PnO administration of drugs known to selectively increase or decrease GABA levels. Design: A within-subjects design was used for microdialysis and microinjection experiments. Setting: University of Michigan. Patients or Participants: Experiments were performed using adult male Crl:CD® (SD)IGS BR (Sprague-Dawley) rats (n = 46). Interventions: PnO administration of hypocretin-1, nipecotic acid (a GABA uptake inhibitor that increases extracellular GABA levels), 3-mercaptopropionic acid (a GABA synthesis inhibitor that decreases extracellular GABA levels; 3-MPA), and Ringer solution (vehicle control). Measurements and Results: Dialysis administration of hypocretin-1 to the PnO caused a statistically significant, concentration- dependent increase in PnO GABA levels. PnO microinjection of hypocretin-1 or nipecotic acid caused a significant increase in wakefulness and a significant decrease in non-rapid eye movement (NREM) sleep and REM sleep. Microinjecting 3-MPA into the PnO caused a significant increase in NREM sleep and REM sleep and a significant decrease in wakefulness. Conclusions: An increase or a decrease in PnO GABA levels causes an increase or decrease, respectively, in wakefulness. Hypocretin-1 may promote wakefulness, at least in part, by increasing GABAergic transmission in the PnO.

Original languageEnglish (US)
Pages (from-to)453-464
Number of pages12
JournalSleep
Volume31
Issue number4
DOIs
StatePublished - May 1 2008
Externally publishedYes

Fingerprint

Wakefulness
gamma-Aminobutyric Acid
REM Sleep
Microinjections
Eye Movements
Sleep
GABA Uptake Inhibitors
3-Mercaptopropionic Acid
Orexins
Pontine Tegmentum
Microdialysis
Sprague Dawley Rats
Dialysis
Peptides
Pharmaceutical Preparations

All Science Journal Classification (ASJC) codes

  • Clinical Neurology
  • Physiology (medical)

Cite this

Pontine reticular formation (PnO) administration of hypocretin-1 increases PnO GABA levels and wakefulness. / Watson, Christopher J.; Soto-Calderon, Haideliza; Lydic, Ralph; Baghdoyan, Helen.

In: Sleep, Vol. 31, No. 4, 01.05.2008, p. 453-464.

Research output: Contribution to journalArticle

@article{2ecbe06c8dec4abbb75259eef66c3e64,
title = "Pontine reticular formation (PnO) administration of hypocretin-1 increases PnO GABA levels and wakefulness",
abstract = "Study Objectives: GABAergic transmission in the oral part of the pontine reticular formation (PnO) increases wakefulness. The hypothalamic peptide hypocretin-1 (orexin A) promotes wakefulness, and the PnO receives hypocretinergic input. The present study tested the hypothesis that PnO administration of hypocretin-1 increases PnO GABA levels and increases wakefulness. This study also tested the hypothesis that wakefulness is either increased or decreased, respectively, by PnO administration of drugs known to selectively increase or decrease GABA levels. Design: A within-subjects design was used for microdialysis and microinjection experiments. Setting: University of Michigan. Patients or Participants: Experiments were performed using adult male Crl:CD{\circledR} (SD)IGS BR (Sprague-Dawley) rats (n = 46). Interventions: PnO administration of hypocretin-1, nipecotic acid (a GABA uptake inhibitor that increases extracellular GABA levels), 3-mercaptopropionic acid (a GABA synthesis inhibitor that decreases extracellular GABA levels; 3-MPA), and Ringer solution (vehicle control). Measurements and Results: Dialysis administration of hypocretin-1 to the PnO caused a statistically significant, concentration- dependent increase in PnO GABA levels. PnO microinjection of hypocretin-1 or nipecotic acid caused a significant increase in wakefulness and a significant decrease in non-rapid eye movement (NREM) sleep and REM sleep. Microinjecting 3-MPA into the PnO caused a significant increase in NREM sleep and REM sleep and a significant decrease in wakefulness. Conclusions: An increase or a decrease in PnO GABA levels causes an increase or decrease, respectively, in wakefulness. Hypocretin-1 may promote wakefulness, at least in part, by increasing GABAergic transmission in the PnO.",
author = "Watson, {Christopher J.} and Haideliza Soto-Calderon and Ralph Lydic and Helen Baghdoyan",
year = "2008",
month = "5",
day = "1",
doi = "10.1093/sleep/31.4.453",
language = "English (US)",
volume = "31",
pages = "453--464",
journal = "Sleep",
issn = "0161-8105",
publisher = "American Academy of Sleep Medicine",
number = "4",

}

TY - JOUR

T1 - Pontine reticular formation (PnO) administration of hypocretin-1 increases PnO GABA levels and wakefulness

AU - Watson, Christopher J.

AU - Soto-Calderon, Haideliza

AU - Lydic, Ralph

AU - Baghdoyan, Helen

PY - 2008/5/1

Y1 - 2008/5/1

N2 - Study Objectives: GABAergic transmission in the oral part of the pontine reticular formation (PnO) increases wakefulness. The hypothalamic peptide hypocretin-1 (orexin A) promotes wakefulness, and the PnO receives hypocretinergic input. The present study tested the hypothesis that PnO administration of hypocretin-1 increases PnO GABA levels and increases wakefulness. This study also tested the hypothesis that wakefulness is either increased or decreased, respectively, by PnO administration of drugs known to selectively increase or decrease GABA levels. Design: A within-subjects design was used for microdialysis and microinjection experiments. Setting: University of Michigan. Patients or Participants: Experiments were performed using adult male Crl:CD® (SD)IGS BR (Sprague-Dawley) rats (n = 46). Interventions: PnO administration of hypocretin-1, nipecotic acid (a GABA uptake inhibitor that increases extracellular GABA levels), 3-mercaptopropionic acid (a GABA synthesis inhibitor that decreases extracellular GABA levels; 3-MPA), and Ringer solution (vehicle control). Measurements and Results: Dialysis administration of hypocretin-1 to the PnO caused a statistically significant, concentration- dependent increase in PnO GABA levels. PnO microinjection of hypocretin-1 or nipecotic acid caused a significant increase in wakefulness and a significant decrease in non-rapid eye movement (NREM) sleep and REM sleep. Microinjecting 3-MPA into the PnO caused a significant increase in NREM sleep and REM sleep and a significant decrease in wakefulness. Conclusions: An increase or a decrease in PnO GABA levels causes an increase or decrease, respectively, in wakefulness. Hypocretin-1 may promote wakefulness, at least in part, by increasing GABAergic transmission in the PnO.

AB - Study Objectives: GABAergic transmission in the oral part of the pontine reticular formation (PnO) increases wakefulness. The hypothalamic peptide hypocretin-1 (orexin A) promotes wakefulness, and the PnO receives hypocretinergic input. The present study tested the hypothesis that PnO administration of hypocretin-1 increases PnO GABA levels and increases wakefulness. This study also tested the hypothesis that wakefulness is either increased or decreased, respectively, by PnO administration of drugs known to selectively increase or decrease GABA levels. Design: A within-subjects design was used for microdialysis and microinjection experiments. Setting: University of Michigan. Patients or Participants: Experiments were performed using adult male Crl:CD® (SD)IGS BR (Sprague-Dawley) rats (n = 46). Interventions: PnO administration of hypocretin-1, nipecotic acid (a GABA uptake inhibitor that increases extracellular GABA levels), 3-mercaptopropionic acid (a GABA synthesis inhibitor that decreases extracellular GABA levels; 3-MPA), and Ringer solution (vehicle control). Measurements and Results: Dialysis administration of hypocretin-1 to the PnO caused a statistically significant, concentration- dependent increase in PnO GABA levels. PnO microinjection of hypocretin-1 or nipecotic acid caused a significant increase in wakefulness and a significant decrease in non-rapid eye movement (NREM) sleep and REM sleep. Microinjecting 3-MPA into the PnO caused a significant increase in NREM sleep and REM sleep and a significant decrease in wakefulness. Conclusions: An increase or a decrease in PnO GABA levels causes an increase or decrease, respectively, in wakefulness. Hypocretin-1 may promote wakefulness, at least in part, by increasing GABAergic transmission in the PnO.

UR - http://www.scopus.com/inward/record.url?scp=43749110731&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=43749110731&partnerID=8YFLogxK

U2 - 10.1093/sleep/31.4.453

DO - 10.1093/sleep/31.4.453

M3 - Article

VL - 31

SP - 453

EP - 464

JO - Sleep

JF - Sleep

SN - 0161-8105

IS - 4

ER -